Published in Clin Exp Immunol on June 01, 2005
Evaluation and management of pulmonary disease in ataxia-telangiectasia. Pediatr Pulmonol (2010) 0.93
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial. Hum Vaccin Immunother (2014) 0.83
Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases. Clin Immunol (2007) 0.80
A precocious cerebellar ataxia and frequent Fever episodes in a 16-month-old infant revealing ataxia-telangiectasia syndrome. Case Reports Immunol (2013) 0.75
Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study. Caspian J Intern Med (2017) 0.75
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J (2000) 11.94
Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat (1998) 4.49
Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature (1988) 3.82
Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet (2003) 3.67
The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet (1995) 3.05
MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet (2002) 2.87
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F. Infect Immun (2002) 1.62
Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol (2002) 1.42
Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Eur J Immunol (2000) 1.28
Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid. J Infect Dis (1980) 1.24
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Variable deletion and duplication at recombination junction ends: implication for staggered double-strand cleavage in class-switch recombination. Proc Natl Acad Sci U S A (2001) 1.21
Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res (1997) 1.19
Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis (2002) 1.13
Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants. Pediatr Infect Dis J (2000) 1.12
Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates. J Immunol Methods (1996) 1.05
Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia. Clin Exp Immunol (2002) 0.98
Essential role for CD40 ligand interactions in T lymphocyte-mediated modulation of the murine immune response to pneumococcal capsular polysaccharides. J Immunol (2002) 0.96
Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media. Clin Infect Dis (2004) 0.95
Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia. J Clin Immunol (1999) 0.93
Immunity to diphtheria and tetanus in England and Wales. Vaccine (2000) 0.92
Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults. Scand J Infect Dis (2001) 0.88
Detection of diphtheria antitoxin by four different methods. Clin Microbiol Infect (1999) 0.87
Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children. Int J Pediatr Otorhinolaryngol (2002) 0.86
Direct B/B-cell interactions in immunoglobulin synthesis. Clin Exp Immunol (2001) 0.85
Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors. Clin Exp Immunol (1996) 0.82
Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia. Pediatr Infect Dis J (2004) 0.81
Antibody response to a seven-valent pneumococcal conjugated vaccine in patients with ataxia-telangiectasia. J Clin Immunol (2004) 0.81
The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clin Exp Immunol (2004) 0.81
Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection. Lancet (2002) 0.81
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
Elution and characterization of lymphocytes from rheumatoid inflammatory tissue. Scand J Immunol (1975) 1.60
Primary immunodeficiency diseases in Norway. J Clin Immunol (2000) 1.48
Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease. Vaccine (2003) 1.46
Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness. Clin Microbiol Infect (2007) 1.43
[Diagnosis and treatment of infections in a neonatal unit--viral infections, spirochete infections and toxoplasma infections]. Tidsskr Nor Laegeforen (1993) 1.39
Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection. Infect Immun (1999) 1.18
Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect Immun (1999) 1.17
Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J Hosp Infect (2001) 1.09
Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Invest (2008) 1.09
Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue. Clin Exp Immunol (1977) 1.05
IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma. Acta Pathol Microbiol Immunol Scand C (1984) 1.05
Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation. J Immunol (1995) 1.00
CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today (1996) 1.00
Membrane characteristics of adherent cells dissociated from rheumatoid synovial tissue. Clin Exp Immunol (1977) 0.97
In vitro mitogen stimulation of synovial fluid lymphocytes from rheumatoid arthritis and juvenile rheumatoid arthritis patients: dissociation between the response to antigens and polyclonal mitogens. Scand J Immunol (1978) 0.96
Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes. J Immunol (1993) 0.95
Psychological outcome in children treated for brain tumor. Pediatr Hematol Oncol (1999) 0.93
Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin Exp Immunol (2006) 0.91
Antigen and unspecific mitogen stimulation of lymphocytes eluted from rheumatoid inflammatory tissue. Scand J Immunol (1976) 0.89
Blood culture isolates during 6 years in a tertiary neonatal intensive care unit. Scand J Infect Dis (1998) 0.88
Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles. Clin Exp Immunol (2010) 0.88
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. Eur J Clin Microbiol Infect Dis (2008) 0.88
Functional comparison of bone marrow-derived macrophages obtained by cultivation in serum-free or serum-supplemented medium. Immunobiology (1986) 0.86
Familial disseminated infection due to atypical mycobacteria with childhood onset. Clin Infect Dis (1998) 0.86
Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice. FEMS Immunol Med Microbiol (2000) 0.85
Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart (2009) 0.84
Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance. Infect Immun (2001) 0.83
Carriage of Streptococcus pneumoniae in healthy Norwegian children attending day-care centres. Eur J Clin Microbiol Infect Dis (2006) 0.82
Discrepancy between results of a commercial enzyme immunoassay kit and immunofluorescence staining for detection of respiratory syncytial virus antigen. Eur J Clin Microbiol Infect Dis (1998) 0.82
Murine monoclonal antibodies against pneumococcal capsular polysaccharide types 4, 8, 22F and 19A/19F. APMIS (1992) 0.82
Alpha fetoprotein is increasing with age in ataxia-telangiectasia. Eur J Paediatr Neurol (2007) 0.82
Protective effect of Plantago major L. Pectin polysaccharide against systemic Streptococcus pneumoniae infection in mice. Scand J Immunol (2000) 0.81
Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor. Infect Immun (1993) 0.81
The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clin Exp Immunol (2004) 0.81
Acremonium strictum fungaemia in a paediatric patient with acute leukaemia. Scand J Infect Dis (2000) 0.80
Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood (2001) 0.80
Seroepidemiological study after a long-distance industrial outbreak of legionnaires' disease. Clin Vaccine Immunol (2009) 0.80
Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1 beta, or TNF-alpha production by human monocytes in vitro. Clin Immunol Immunopathol (1991) 0.80
The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency. J Perinat Med (2000) 0.79
Polymyxin B stimulates production of complement components and cytokines in human monocytes. Antimicrob Agents Chemother (1995) 0.79
Modulation of C3 gene expression in HepG2 human hepatoma cells. Immunol Lett (2001) 0.79
Calcium-dependent eicosanoid metabolism by concanavalin A-stimulated human monocytes in vitro. Synergism with phorbol ester indicates separate regulation of leukotriene B4 synthesis and release. J Immunol (1991) 0.79
Transforming growth factor beta modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytes. J Leukoc Biol (1995) 0.78
Point-of-use filtration method for the prevention of fungal contamination of hospital water. J Hosp Infect (2010) 0.78
Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro. Blood (1996) 0.78
Halogenated organic compounds and the human immune system: preliminary report on a study in hobby fishermen. Arch Toxicol Suppl (1996) 0.78
Lymphocytes eluted from synovial tissue of juvenile rheumatoid arthritis patients. Arthritis Rheum (1977) 0.78
Various Candida and Torulopsis species differ in their ability to induce the production of C3, factor B and granulocyte-macrophage colony-stimulating factor (GM-CSF) in human monocyte cultures. J Med Microbiol (1995) 0.78
Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes. Scand J Immunol (1995) 0.78
C-reactive protein (CRP) response patterns in neonatal septicaemia. APMIS (1999) 0.78
Human IgE production in hu-PBL-SCID mice injected with birch pollen and diesel exhaust particles. Toxicology (1998) 0.78
Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens. Clin Immunol (2001) 0.77
Predictive value of immunologic parameters and HIV RNA in relation to humoral pneumococcal polysaccharide vaccine responses in patients with HIV infection. Eur J Clin Microbiol Infect Dis (2002) 0.77
Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma. Acta Pathol Microbiol Immunol Scand C (1984) 0.77
Interleukin-13 and human immunoglobulin E production in severe combined immunodeficiency mice transplanted with human peripheral blood lymphocytes. Scand J Immunol (1999) 0.77
X-linked thrombocytopenia and thrombocytopathia: attenuated Wiskott-Aldrich syndrome. Functional and morphological studies of platelets and lymphocytes. Thromb Haemost (1991) 0.77
Alterations in the terminal complement pathway in leukopenic children with malignant diseases during episodes with evidence of infection. Complement Inflamm (1989) 0.77
Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production. Thromb Res (1995) 0.77
[Salmonella infection from turtles]. Tidsskr Nor Laegeforen (2000) 0.76
Pectic polysaccharides isolated from Malian medicinal plants protect against Streptococcus pneumoniae in a mouse pneumococcal infection model. Scand J Immunol (2013) 0.76
[Subcutaneous immunoglobulin and support program: what level of interest of patients?]. Rev Med Suisse (2015) 0.75
[Hemangioma and vascular malformations. Diagnosis and treatment]. Tidsskr Nor Laegeforen (1997) 0.75
[Rotavirus in stools from hospitalized children]. Tidsskr Nor Laegeforen (1989) 0.75
[Tuberculosis in Norwegian children--diagnostic challenges]. Tidsskr Nor Laegeforen (2000) 0.75
Specific human IgE response after immunization with birch pollen in scid mice transplanted with human peripheral blood mononuclear cells-A model for human allergy? Toxicol In Vitro (1994) 0.75
Autoantibodies in individuals splenectomized because of trauma. Scand J Haematol (1986) 0.75
Antibody-dependent cytotoxicity mediated by cells eluted from synovial tissues of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Scand J Immunol (1977) 0.75
[Nutritional support of children with cancer]. Tidsskr Nor Laegeforen (1987) 0.75
[Recent methods in histologic diagnosis of tumors. II. Electron microscopy]. Tidsskr Nor Laegeforen (1983) 0.75
Antibiotic susceptibility of blood culture isolates after nearly two decades with netilmicin and ampicillin in neonatal septicaemia. APMIS (1999) 0.75
The immune response to pneumococcal polysaccharide vaccine in zinc-depleted mice. Scand J Immunol (2003) 0.75
Incidence and prognostic importance of silent ischaemia after PTCA: a prospective study. Eur Heart J (1988) 0.75
Lymphocytes from synovial tissue of a boy with X-linked hypogammaglobulinemia and chronic polyarthritis. Arthritis Rheum (1979) 0.75
Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3. Arch Virol (1997) 0.75
[Principles and mechanism of action of drug therapy of rheumatoid arthritis]. Tidsskr Nor Laegeforen (1980) 0.75
Identification and functional characterization of monocytes in rheumatoid synovial fluid. Int Arch Allergy Appl Immunol (1981) 0.75
[Utilization of anti-infective agents in pediatric departments in health region 2]. Tidsskr Nor Laegeforen (1999) 0.75
[Chest X-ray examination as a screening procedure. Experiences from the armed forces in 1978]. Tidsskr Nor Laegeforen (1982) 0.75
Total and birch pollen-specific human IgE in mice with severe combined immunodeficiency transplanted with human peripheral blood lymphocytes: donor dependence, seasonal variation and in vivo half-life. Int Arch Allergy Immunol (1997) 0.75
[Diagnosis and treatment of infections in a neonatal unit--bacterial and fungal infections]. Tidsskr Nor Laegeforen (1993) 0.75
[Recent methods in the histologic diagnosis of tumors. I. Immunohistochemistry]. Tidsskr Nor Laegeforen (1983) 0.75
Characterization of antibody-dependent cell-mediated cytotoxicity in rheumatoid synovial fluid. Scand J Rheumatol (1981) 0.75
[Cytomegalovirus infection in neonates. Diagnosis and therapeutic experiences]. Tidsskr Nor Laegeforen (1997) 0.75
Plaque-forming, antibody-dependent, cytotoxic cells with monocytic properties are present in rheumatoid synovial tissue. Scand J Rheumatol (1981) 0.75
Monocyte cytotoxicity in connective tissue diseases. Correlation with disease groups. Scand J Rheumatol (1981) 0.75
Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography. Scand J Immunol (2004) 0.75
Cerebral venous thrombosis and Escherichia coli infection in neonates. Acta Paediatr (2003) 0.75
Unexpected medical coincidences require systematic and careful strategies: an example. Arch Dis Child (2003) 0.75